Glioblastoma multiforme (GBM) is the most common and aggressive form of primary
malignant brain tumor in adults, with poor prognosis. Extracellular vesicles (EVs) are key …

The main chemical component of cannabis, cannabidiol (CBD), has been shown to have
antitumor properties. The present study examined the in vitro effects of CBD on human …

Objective Cannabinoids are able to reduce tumor growth in xenograft models, but their
therapeutic potential as anti-cancer drugs in humans is unclear yet. In vitro studies of the …

Cannabinoids are a group of structurally heterogeneous but pharmacologically related
compounds, including plant-derived cannabinoids, synthetic substances and endogenous …

Background. The active components of Cannabis sativa L., Cannabinoids, traditionally used
in the field of cancer for alleviation of pain, nausea, wasting and improvement of well-being …

Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …

Despite numerous studies conducted over the past decade, the exact role of the
cannabinoid system in cancer development remains unclear. Though research has focused …

Simple Summary Drug resistance is the key factor contributing to the therapeutic failure of
lung cancer and the deaths related to lung cancer. Our study demonstrated that small …

Gliomas, in particular glioblastoma multiforme or grade IV astrocytoma, are the most
frequent class of malignant primary brain tumours and one of the most aggressive forms of …

Cannabinoids are known to control the cell survival/death decision, leading to different
outcomes that depend on the nature of the target cell and its proliferative or differentiation …